Grove Bank & Trust Lowers Position in Agilent Technologies, Inc. (NYSE:A)

Grove Bank & Trust cut its stake in Agilent Technologies, Inc. (NYSE:A) by 67.0% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 655 shares of the medical research company’s stock after selling 1,329 shares during the period. Grove Bank & Trust’s holdings in Agilent Technologies were worth $97,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of A. Vanguard Group Inc. lifted its holdings in Agilent Technologies by 18.2% in the first quarter. Vanguard Group Inc. now owns 29,884,345 shares of the medical research company’s stock worth $4,348,471,000 after buying an additional 4,605,228 shares during the period. Price T Rowe Associates Inc. MD lifted its holdings in shares of Agilent Technologies by 13.9% during the first quarter. Price T Rowe Associates Inc. MD now owns 8,542,054 shares of the medical research company’s stock valued at $1,242,956,000 after purchasing an additional 1,042,926 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in shares of Agilent Technologies by 5.7% during the second quarter. Massachusetts Financial Services Co. MA now owns 15,064,660 shares of the medical research company’s stock valued at $1,952,832,000 after purchasing an additional 809,149 shares during the last quarter. Champlain Investment Partners LLC purchased a new position in shares of Agilent Technologies during the first quarter valued at approximately $61,218,000. Finally, Marshall Wace LLP lifted its holdings in shares of Agilent Technologies by 48.6% during the second quarter. Marshall Wace LLP now owns 957,128 shares of the medical research company’s stock valued at $124,073,000 after purchasing an additional 313,155 shares during the last quarter. 87.42% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Agilent Technologies

In related news, SVP Dominique Grau sold 9,990 shares of the company’s stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the completion of the transaction, the senior vice president now owns 40,011 shares of the company’s stock, valued at approximately $5,801,595. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. In related news, SVP Dominique Grau sold 9,990 shares of the company’s stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the completion of the transaction, the senior vice president now owns 40,011 shares of the company’s stock, valued at approximately $5,801,595. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Padraig Mcdonnell sold 1,958 shares of the company’s stock in a transaction on Friday, July 26th. The stock was sold at an average price of $140.00, for a total transaction of $274,120.00. Following the completion of the transaction, the chief executive officer now directly owns 26,076 shares of the company’s stock, valued at $3,650,640. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 13,953 shares of company stock worth $2,013,630 in the last three months. Corporate insiders own 0.33% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the stock. Evercore ISI raised their price target on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an “in-line” rating in a research report on Tuesday, October 1st. UBS Group raised their price target on shares of Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a research report on Thursday, August 22nd. Stifel Nicolaus reissued a “buy” rating and set a $151.00 price target on shares of Agilent Technologies in a research report on Monday, August 26th. Wolfe Research downgraded shares of Agilent Technologies from an “outperform” rating to a “peer perform” rating in a research report on Thursday, June 27th. Finally, Barclays raised their price target on shares of Agilent Technologies from $125.00 to $135.00 and gave the company an “underweight” rating in a research report on Friday, August 23rd. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $143.64.

Agilent Technologies Trading Up 0.3 %

NYSE:A opened at $144.25 on Tuesday. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.78 and a quick ratio of 1.37. The firm has a market capitalization of $42.09 billion, a price-to-earnings ratio of 34.10, a price-to-earnings-growth ratio of 6.96 and a beta of 1.05. Agilent Technologies, Inc. has a one year low of $96.80 and a one year high of $155.35. The business has a fifty day moving average price of $140.70 and a 200-day moving average price of $138.87.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, August 21st. The medical research company reported $1.32 EPS for the quarter, topping the consensus estimate of $1.26 by $0.06. The firm had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.56 billion. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. Agilent Technologies’s revenue was down 5.6% on a year-over-year basis. During the same period in the prior year, the business posted $1.43 EPS. Sell-side analysts forecast that Agilent Technologies, Inc. will post 5.24 EPS for the current year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st will be paid a $0.236 dividend. The ex-dividend date of this dividend is Tuesday, October 1st. This represents a $0.94 annualized dividend and a dividend yield of 0.65%. Agilent Technologies’s dividend payout ratio (DPR) is 22.22%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.